Dow Up 0.08% Nasdaq Down 0.30%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
6.36 Down 0.14(2.15%) Sep 19, 4:00PM EDT
Prev Close:6.50
Open:6.51
Bid:N/A
Ask:7.51 x 1000
1y Target Est:15.80
Beta:-0.520
Next Earnings Date:N/A
Day's Range:6.35 - 6.63
52wk Range:5.06 - 15.67
Volume:130,340
Avg Vol (3m):492,875
Market Cap:98.47M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CNAT

Comparison

Symbol% ChgMkt Cap
CNATDown 2.15%98.47M
GALTDown 5.21%116.39M
ICPTDown 3.31%5.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.62
Quarterly EPS Est (Sep-14) :-0.44
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-4.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback